Study guide
19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation
Key Takeaways Explain This Topic AI
Standardized A-scan echography, pioneered by Karl Ossoinig, utilizes a calibrated 8-MHz non-focused parallel-beam transducer paired with a specialized S-shaped amplifier curve to deliver objective, reproducible quantitative tissue characterization.
The standardized gain ('Tissue Sensitivity') is calibrated on an artificial tissue phantom to ensure uniform spike heights across certified echographs worldwide, establishing a universal diagnostic baseline.
Acoustic spikes display echo amplitude (vertical Y-axis, 0% to 100% baseline-to-saturation) plotted against acoustic transit time/distance (horizontal X-axis); a perpendicular healthy retina generates a 100% saturated spike.
Internal tissue reflectivity is quantitatively categorized as low (<20–40%), medium (40–60%), high (60–95%), or extremely high (100% with shadowing), which diagnostically separates choroidal melanoma (low-to-medium regular reflectivity) from choroidal hemangioma (high, uniform reflectivity) and metastatic carcinoma (medium-to-high, irregular reflectivity).
The angle of kappa (angle of acoustic decay) quantifies the slope of descending internal tumor spikes, measuring sound absorption through the lesion, while spontaneous vertical spike oscillations detect intrinsic tumor vascularity.
Last updated: September 2026
Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation
Core Clinical Mandate: Standardized diagnostic A-scan echography is an objective, quantitative in vivo biopsy tool. Unlike biometry A-scans engineered solely for linear distance measurement, standardized A-scan utilizes a calibrated, non-focused 8-MHz transducer and an S-shaped amplifier curve to quantify histological tissue architecture, internal reflectivity, sound attenuation, and microvascular flow.
The Ossoinig Standardized Echography System
Developed by Dr. Karl Ossoinig in the late 1960s, Standardized Echography was established to eliminate operator-dependent variability and equipment inconsistencies. Prior to standardization, altering gain or using uncalibrated focused probes produced wildly fluctuating echo patterns, rendering tissue diagnosis unreliable.
Standardized Diagnostic A-Scan vs. Biometric A-Scan
A critical distinction tested on advanced certification exams is the fundamental difference between biometry A-scans and standardized diagnostic A-scans:
Technical Parameter Standardized Diagnostic A-Scan Biometric A-Scan (IOL Biometer)
Primary Objective Quantitative tissue characterization & tumor differentiation Linear axial length measurement for IOL power calculation
Transducer Design 8-MHz non-focused, parallel sound beam 10–12 MHz focused sound beam
Beam Profile Cylindrical parallel beam (ensures uniform spike height across depth) Converging/diverging conical beam (optimizes surface echo sharpness)
Amplifier Characteristics Specialized S-shaped amplifier curve Linear or simple logarithmic amplifier
Gain Calibration Standardized Gain (Tissue Sensitivity) calibrated on a tissue phantom Uncalibrated user-adjusted gain or automatic electronic thresholding
Clinical Display Full 0% to 100% calibrated vertical spike amplitudes Gates and threshold markers measuring peak-to-peak transit time Key Engineering Principle:
A focused beam concentrates energy at the focal point, causing identical histological tissue
to display high reflectivity at the focal zone but low reflectivity elsewhere.
A non-focused parallel beam emits a uniform cylindrical column of sound, ensuring that
spike height reflects pure intrinsic tissue histology regardless of tumor depth.
Loading diagram... Standardized A-Scan Trace: Spike Anatomy and Angle of Kappa
- Standardized Gain Calibration (Tissue Sensitivity) and Amplifier Dynamics
- The S-Shaped Amplifier Curve
In conventional linear ultrasound systems, weak echoes from fine tissue interfaces are lost below the baseline, while strong echoes quickly saturate at 100% screen height, destroying the ability to differentiate tissue density. Conversely, purely logarithmic amplifiers compress the entire dynamic range into a narrow band, obscuring subtle diagnostic differences.
The standardized A-scan solves this through an S-shaped amplifier transfer curve :
Lower Range (0% to 15%): Highly compressed to suppress background electronic baseline noise and weak thermal artifacts.
Middle Diagnostic Range (15% to 85%): Exceptionally linear and expanded . This steep linear middle zone maximizes contrast and vertical spike height separation between differing tissue cellular densities.
Upper Range (85% to 100%): Compressed near 100% saturation to prevent blooming and echo distortion from massive specular reflectors (such as the sclera or calcifications).
Tissue Sensitivity (Standardized Gain) Calibration
To guarantee that an echogram captured in New York exhibits identical spike heights to one captured in Tokyo or London, every standardized A-scan unit undergoes Tissue Sensitivity calibration using a standardized tissue phantom (the Ossoinig calibration block, composed of calibrated silicone):
The 8-MHz non-focused probe is placed onto the calibration block with acoustic coupling gel.
The system gain is adjusted until the calibration echo spike matches the exact reference line marked on the screen (or specified decibel calibration value provided by the manufacturer).
This calibrated decibel level is termed Standardized Gain (or Tissue Sensitivity) .
Clinical Gain Settings
Standardized Gain (Tissue Sensitivity): The mandatory setting for all quantitative tumor evaluations, including internal reflectivity, structural homogeneity, acoustic attenuation, and vascular flow detection.
High Gain (Tissue Sensitivity + 6 to 12 dB): Maximizes electronic sensitivity to detect faint vitreous opacities, fine posterior hyaloid membranes, and vitreous traction bands that produce sub-threshold echoes at standardized gain.
Low Gain (Tissue Sensitivity - 9 to 15 dB): Used to eliminate soft tissue echoes and verify hyper-dense interfaces, such as calcified optic disc drusen, scleral foreign bodies, or choroidal osteomas.
Quantitative Criteria for Tissue Characterization
Standardized echography classifies intraocular mass lesions and structural membranes according to four primary quantitative criteria: Internal Reflectivity , Internal Structure , Acoustic Attenuation , and Spontaneous Vascularity .
1. Internal Reflectivity
Internal reflectivity is determined by the height of internal tumor spikes relative to the initial surface spike, measured at Standardized Gain with the sound beam directed perpendicular to the lesion:
Extremely Low / Null (0% to 10%): Completely fluid-filled, acoustically clear lesions lacking internal interfaces. Examples: clear vitreous, serous subretinal fluid, simple epithelial iris/ciliary body cysts, epithelial inclusion cysts.
Low (10% to 40%): Densely packed, highly cellular tissue composed of small, uniform cells with minimal fibrous stroma and few internal acoustic interfaces. Classic hallmark of Choroidal Melanoma (spindle or epithelioid cell sheets).
Medium (40% to 60%): Moderately cellular tissue interspersed with variable fibrous connective tissue or glandular structures. Characteristic of Metastatic Choroidal Carcinoma , medulloepitheliomas, and necrotic melanomas.
High (60% to 95%): Highly heterogeneous tissue containing numerous acoustic interfaces, such as large vascular channels, dense collagen bundles, or fibrous trabeculae. Classic hallmark of Choroidal Hemangioma and compact choroidal nevi.
Extremely High (100% with Acoustic Shadowing): Densely calcified, bony, or foreign materials that reflect 100% of incident sound and totally extinguish posterior echoes. Classic for Choroidal Osteoma , calcified retinoblastoma, phthisis bulbi calcifications, and scleral buckles.
2. Internal Structure (Homogeneity vs. Heterogeneity)
Internal structure describes the consistency of spike heights and spacing across the internal width of the tumor:
Regular (Homogeneous) Structure: Internal spikes maintain uniform, predictable heights and equal spacing throughout the lesion. Typical of uncomplicated choroidal melanoma (regular cellular packing) and choroidal hemangioma (uniform cavernous vascular lakes).
Irregular (Heterogeneous) Structure: Internal spikes display erratic, wildly fluctuating heights (ranging from 10% to 80% within the same mass) and irregular spacing. Pathognomonic for metastatic carcinoma (variable glandular lumens, necrotic foci, and fibrous septa) or melanomas with extensive internal necrosis or hemorrhage.
3. Acoustic Attenuation and the Angle of Kappa ( κ \kappa κ )
As the acoustic beam traverses a solid mass, sound energy is progressively absorbed and converted to heat. This energy loss is visually reflected on the A-scan trace as a downward slope in the peaks of consecutive internal spikes:
The Angle of Kappa ( κ \kappa κ ): The angle formed between the horizontal baseline and an imaginary line connecting the tops of the internal tumor spikes.
Steep Angle of Kappa (Marked Attenuation): The internal spikes decline rapidly from left to right across the lesion. Highly dense cellular tumors (such as spindle-cell choroidal melanomas) absorb sound rapidly, producing a steep angle of kappa.
Flat Angle of Kappa (Minimal Attenuation): Internal spikes maintain their height from front to back without significant decline. Vascular cavernous lesions (such as choroidal hemangiomas) allow sound to pass with minimal absorption, yielding a nearly flat angle of kappa.
4. Spontaneous Internal Vascularity
By observing the real-time standardized A-scan trace without moving the probe, the examiner evaluates intrinsic blood flow:
Vascular Spontaneous Mobility: Appears as rapid vertical flickering or dancing oscillations of the internal spikes, occurring in synchrony with choroidal or retinal arterial pulses.
Prominent, rhythmic spike flickering signifies fast arteriovenous blood flow within the neovascular beds of choroidal melanomas and vascular malformations. Purely fibrous lesions and non-vascularized exudates exhibit completely stationary, motionless spikes.
Comparative Differential Diagnosis of Posterior Segment Masses
The synthesis of standardized A-scan quantitative metrics provides an exceptionally accurate histological differentiation of intraocular tumors:
Neoplasm / Mass Internal Reflectivity (%) Internal Structure Angle of Kappa ( κ \kappa κ ) Spontaneous Vascularity Key B-Scan Morphological Hallmarks
Choroidal Melanoma Low to Medium (10–40%) Regular (Homogeneous) Steep (High attenuation) Present (Rapid spike flicker) Collar-button / mushroom configuration; choroidal excavation; acoustic hollowness
Choroidal Hemangioma High (60–95%) Regular (Homogeneous) Flat (Low attenuation) Absent or minimal Dome-shaped or diffuse; acoustically solid; no choroidal excavation
Metastatic Carcinoma Medium to High (40–80%) Irregular (Heterogeneous) Variable / Moderate Absent Broad-based, plateau or lobulated; overlying subretinal fluid; no excavation
Choroidal Osteoma 100% (Saturated Spike) N/A (Sound blocked) N/A Absent Intensely bright calcified plaque; dense posterior acoustic shadowing extinguishing sclera
Choroidal Nevus High (60–90%) Regular Flat Absent Thin (<2.0 mm thickness); dome-shaped; lacks collar-button or excavation
Retinoblastoma Extremely High (Calcified foci) Irregular Rapid attenuation behind calcium Variable Heterogeneous mass in pediatric patient; calcified acoustic spikes persisting at low gain